Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Lumen Bioscience, Inc.

Lumen Bioscience, Inc.

Stage unknownSeattle, WABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Apr 1, 2025
    Form D equity offering · $0 (form d sold)
    Fact SEC EDGAR Form D data sets (quarterly) · “Lumen Bioscience, Inc. filed Form D: no sales yet of $23,000,000, Biotechnology”
  2. Nov 19, 2024
    Form D equity offering · $0 (form d sold)
    Fact SEC EDGAR Form D data sets (quarterly) · “Lumen Bioscience, Inc. filed Form D: no sales yet of $18,345,489, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
5 officers, 5 directors
Timeline
2
  1. Apr 1, 2025
    Lumen Bioscience, Inc. filed Form D: no sales yet of $23,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Nov 19, 2024
    Lumen Bioscience, Inc. filed Form D: no sales yet of $18,345,489, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
26 observations
Every observation on this company